Option chain shows key data for Hennessy Advisors, Inc. - 4.875% Notes due 2026's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Hennessy Advisors, Inc. - 4.875% Notes due 2026.

Hennessy Advisors, Inc. - 4.875% Notes due 2026 (NASDAQ:HNNAZ) Stock, Option Chain

Hennessy Advisors, Inc. - 4.875% Notes due 2026

<p>Evercore ISI Group  analyst Steve Sakwa   maintains Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) with a In-Line and raises the price target from $155 to $159.</p>


News

Price Target

Analyst Ratings

Evercore ISI Group Maintains In-Line on Mid-America Apartment, Raises Price Target to $159

<p>DA Davidson  analyst Brian Holland   maintains Flowers Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>) with a Neutral and lowers the price target from $24 to $21.</p>


DA Davidson Maintains Neutral on Flowers Foods, Lowers Price Target to $21

<p>Evercore ISI Group  analyst Chris McNally   maintains Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>) with a In-Line and lowers the price target from $125 to $110.</p>


Evercore ISI Group Maintains In-Line on Lear, Lowers Price Target to $110

<p>Evercore ISI Group  analyst Omar Saad   maintains Canada Goose Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) with a In-Line and lowers the price target from $13 to $10.</p>


GOOS

Evercore ISI Group Maintains In-Line on Canada Goose Hldgs, Lowers Price Target to $10

<p>Deep-pocketed investors have adopted a bullish approach towards First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in FSLR usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for First Solar. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 40% bearish. Among these notable options, 6 are puts, totaling $354,030, and 4 are calls, amounting to $304,231.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $130.0 to $300.0 for First Solar during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for First Solar's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across First Solar's significant trades, within a strike price range of $130.0 to $300.0, over the past month.</p>
<h3>First Solar Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739203233_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>FSLR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/14/25</td>
<td>$1.49</td>
<td>$0.49</td>
<td>$1.0</td>
<td>$180.00</td>
<td>$200.0K</td>
<td>1.1K</td>
<td align="right">1</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$8.45</td>
<td>$8.15</td>
<td>$8.45</td>
<td>$160.00</td>
<td>$84.4K</td>
<td>2.9K</td>
<td align="right">110</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$17.0</td>
<td>$16.2</td>
<td>$16.2</td>
<td>$175.00</td>
<td>$81.0K</td>
<td>2.2K</td>
<td align="right">50</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$13.6</td>
<td>$13.2</td>
<td>$13.35</td>
<td>$170.00</td>
<td>$61.4K</td>
<td>1.5K</td>
<td align="right">58</td>
</tr>
<tr>
<td>FSLR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$16.1</td>
<td>$15.95</td>
<td>$16.1</td>
<td>$175.00</td>
<td>$56.3K</td>
<td>2.2K</td>
<td align="right">86</td>
</tr>
</tbody>
</table>
</p>
<h3>About First Solar</h3>
<p>First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.</p>
<h3>Current Position of First Solar</h3>
<ul>
<li>Currently trading with a volume of 426,819, the FSLR's price is down by -0.58%, now at $167.37. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 15 days.</li>
</ul>
<h3>Professional Analyst Ratings for First Solar</h3>
<p>A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $279.5.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from B of A Securities persists with their Buy rating on First Solar, maintaining a target price of $236.<br />
&#x2A; Reflecting concerns, an analyst from Guggenheim lowers its rating to Buy with a new price target of $335.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on First Solar, maintaining a target price of $273.<br />
&#x2A; In a positive move, an analyst from Seaport Global has upgraded their rating to Buy and adjusted the price target to $274. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest First Solar options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Markets

FSLR

First Solar's Options: A Look at What the Big Money is Thinking

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Occidental Petroleum</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with OXY, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 11 options trades for <strong>Occidental Petroleum</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 9% bullish and 72%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $33,450, and 10, calls, for a total amount of $422,360.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $70.0 for Occidental Petroleum over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Occidental Petroleum's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Occidental Petroleum's substantial trades, within a strike price spectrum from $50.0 to $70.0 over the preceding 30 days.</p>
<h3>Occidental Petroleum Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739203228_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$7.45</td>
<td>$7.1</td>
<td>$7.23</td>
<td>$50.00</td>
<td>$72.3K</td>
<td>3.4K</td>
<td>103</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.36</td>
<td>$2.31</td>
<td>$2.31</td>
<td>$50.00</td>
<td>$46.2K</td>
<td>10.4K</td>
<td>1.0K</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.39</td>
<td>$2.26</td>
<td>$2.26</td>
<td>$50.00</td>
<td>$45.1K</td>
<td>10.4K</td>
<td>210</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.3</td>
<td>$2.25</td>
<td>$2.25</td>
<td>$50.00</td>
<td>$45.0K</td>
<td>10.4K</td>
<td>612</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.28</td>
<td>$2.23</td>
<td>$2.24</td>
<td>$50.00</td>
<td>$44.8K</td>
<td>10.4K</td>
<td>613</td>
</tr>
</tbody>
</table>
</p>
<h3>About Occidental Petroleum</h3>
<p>Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,234 thousand barrels of oil equivalent per day in 2023 at a ratio of roughly 50% oil and natural gas liquids and 50% natural gas.</p>
<h3>Where Is Occidental Petroleum Standing Right Now?</h3>
<ul>
<li>With a volume of 2,633,164, the price of OXY is up 2.33% at $47.87. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 8 days.</li>
</ul>
<h3>What The Experts Say On Occidental Petroleum</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $51.5.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on Occidental Petroleum, which currently sits at a price target of $58.<br />
&#x2A; An analyst from Goldman Sachs has revised its rating downward to Sell, adjusting the price target to $45. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Occidental Petroleum with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Occidental Petroleum's Options Frenzy: What You Need to Know

<p>Deep-pocketed investors have adopted a bearish approach towards Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GILD usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Gilead Sciences. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 33% leaning bullish and 55% bearish. Among these notable options, 6 are puts, totaling $182,719, and 3 are calls, amounting to $98,565.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $80.0 and $105.0 for Gilead Sciences, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Gilead Sciences's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Gilead Sciences's significant trades, within a strike price range of $80.0 to $105.0, over the past month.</p>
<h3>Gilead Sciences Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739203222_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$9.3</td>
<td>$9.1</td>
<td>$9.1</td>
<td>$92.50</td>
<td>$35.4K</td>
<td>203</td>
<td>49</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/14/25</td>
<td>$0.92</td>
<td>$0.63</td>
<td>$0.8</td>
<td>$91.00</td>
<td>$34.8K</td>
<td>14</td>
<td>1.0K</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$22.05</td>
<td>$21.95</td>
<td>$22.05</td>
<td>$80.00</td>
<td>$33.0K</td>
<td>126</td>
<td>15</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$8.25</td>
<td>$7.5</td>
<td>$8.1</td>
<td>$102.00</td>
<td>$32.4K</td>
<td>1.3K</td>
<td>82</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$7.75</td>
<td>$7.2</td>
<td>$7.75</td>
<td>$102.00</td>
<td>$31.0K</td>
<td>1.3K</td>
<td>460</td>
</tr>
</tbody>
</table>
</p>
<h3>About Gilead Sciences</h3>
<p>Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).</p>
<p>After a thorough review of the options trading surrounding Gilead Sciences, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Gilead Sciences</h3>
<ul>
<li>Currently trading with a volume of 1,766,908, the GILD's price is down by -0.86%, now at $95.21. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 1 days.</li>
</ul>
<h3>What Analysts Are Saying About Gilead Sciences</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $99.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Gilead Sciences, targeting a price of $115.<br />
&#x2A; An analyst from RBC Capital downgraded its action to Sector Perform with a price target of $84. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Gilead Sciences options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


GILD

Gilead Sciences Options Trading: A Deep Dive into Market Sentiment

WIIM

CTRA

EQNR

SLNG

Shares of oil and gas companies are trading higher. Traders may be evaluating amid ongoing global trade war concerns, which has driven volatility in commodity prices.

<p>Cummins (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) has outperformed the market over the past 15 years by 1.22% on an annualized basis producing an average annual return of 13.26%. Currently, Cummins has a market capitalization of $51.01 billion. </p>
<p><strong>Buying $1000 In CMI:</strong> If an investor had bought $1000 of CMI stock 15 years ago, it would be worth <strong>$6,471.46</strong> today based on a price of $371.86 for CMI at the time of writing.</p>
<h3>Cummins's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739203211_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

<p>Evercore ISI Group  analyst Chris McNally   maintains Ford Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) with a In-Line and lowers the price target from $11 to $10.</p>


Evercore ISI Group Maintains In-Line on Ford Motor, Lowers Price Target to $10

<p>DA Davidson  analyst Brandon Rolle   maintains MasterCraft Boat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCFT#NASDAQ">MCFT</a>) with a Neutral and lowers the price target from $23 to $22.</p>


MCFT

DA Davidson Maintains Neutral on MasterCraft Boat Hldgs, Lowers Price Target to $22

<p>Evercore ISI Group  analyst Steve Sakwa   maintains Essex Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESS#NYSE">ESS</a>) with a In-Line and raises the price target from $297 to $302.</p>


Evercore ISI Group Maintains In-Line on Essex Property Trust, Raises Price Target to $302

<p>DA Davidson  analyst Brian Holland   maintains Lancaster Colony (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LANC#NASDAQ">LANC</a>) with a Neutral and raises the price target from $192 to $207.</p>


LANC

DA Davidson Maintains Neutral on Lancaster Colony, Raises Price Target to $207

<p>Evercore ISI Group  analyst Steve Sakwa   maintains Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) with a In-Line and raises the price target from $74 to $76.</p>


Evercore ISI Group Maintains In-Line on Equity Residential, Raises Price Target to $76

<p>Evercore ISI Group  analyst Steve Sakwa   maintains Camden Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) with a In-Line and raises the price target from $118 to $127.</p>


Evercore ISI Group Maintains In-Line on Camden Prop Trust, Raises Price Target to $127

<p>DA Davidson  analyst Gil Luria   maintains Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) with a Buy and raises the price target from $150 to $165.</p>


DDOG

DA Davidson Maintains Buy on Datadog, Raises Price Target to $165

<p>Evercore ISI Group  analyst John Pancari   maintains Cullen/Frost Bankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFR#NYSE">CFR</a>) with a Underperform and raises the price target from $136 to $144.</p>


Evercore ISI Group Maintains Underperform on Cullen/Frost Bankers, Raises Price Target to $144

<p><i>New partnership brings Affirm's biweekly and monthly payment plans to approved patients</i><br /><br /><i>Launch further adds to Affirm's over 90% year-over-year growth of active healthcare providers</i></p>
<p>Coast Dental, a prominent leader in dental healthcare, today announced that it has partnered with Affirm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), the payment network that empowers consumers and helps merchants drive growth. This collaboration brings Affirm's flexible, transparent pay-over-time options to approved Coast Dental patients purchasing general and specialty dental services, including exams, cleanings, veneers, and CoastClear Aligners.</p>
<p>Now patients across Coast Dental's 100 locations in Florida, Georgia, and Texas can choose Affirm's biweekly or monthly payment plans at checkout. The process is simple: patients scan the QR code with their smartphone and complete a quick eligibility check. If approved, they can choose from customized biweekly or monthly payment plans – with as low as 0% APR – and finalize their purchase. As always, Affirm only approves financing for amounts it determines can be repaid responsibly and never charges late or hidden fees.</p>


AFRM

Reported Earlier, Coast Dental Partners With Affirm To Offer A Smarter Way To Pay For Dental Services Across 100 Locations; Launch Further Adds To Affirm's Over 90% YoY Growth Of Active Healthcare Providers

<p>Shares of digital technology major <strong>Cisco Systems Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher</a> on Monday.</p>
<p>The company has introduced an AI solution in collaboration with Mistral AI, signaling a major advancement in its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43588406/cisco-and-mistral-ai-partner-to-deliver-on-ciscos-mission-to-transform-the-customer-experience-wit" rel="noreferrer noopener">Customer Experience (CX) initiatives</a>.</p>
<p>The AI Renewals Agent, the initial product in a series of AI tools co-developed by Cisco and Mistral, simplifies the renewal proposal process by processing data from more than 50 sources.</p>
<p>&#8220;The AI Renewals Agent is an important milestone and the first of many innovative solutions that we&#8217;re going to build together. The impact on our teams is also significant as we continue to look at opportunities to simplify and reduce friction in their jobs,&#8221; said <strong>Liz Centoni</strong>, Executive Vice President and Chief Customer Experience Officer, Cisco.</p>
<p>It delivers tailored recommendations, sentiment analysis, and automates tasks, enhancing customer interaction and satisfaction.</p>
<p>The tool targets a 20% reduction in time spent creating proposals. Significantly, the AI Renewals Agent runs on-premises, ensuring data security, privacy, and compliance while optimizing costs and performance.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43563232/software-company-solarwinds-to-go-private-in-44b-deal-stocks-skyrocket" rel="noreferrer noopener">Software Company SolarWinds Agrees To Go Private In $4.4B Deal</a></strong></p>
<p><strong>Arthur Mensch</strong>, CEO, Mistral AI, stated, &#8220;It demonstrates how GenAI can enhance access to rich and complex information sources, deliver critical value to Cisco&#8217;s customers and ecosystem, and save considerable time for all stakeholders involved.&#8221;</p>
<p>In January, Cisco unveiled Cisco AI Defense, a solution aimed at facilitating and safeguarding <a target="_blank" href="https://www.benzinga.com/25/01/43063294/whats-going-on-with-cisco-systems-stock-on-friday" rel="noreferrer noopener">AI transformation for businesses</a>.</p>
<p>Founded in April 2023 by former engineers from Google DeepMind and Meta, Mistral also <a href="https://www.benzinga.com/25/01/43020678/french-ai-startup-founded-by-former-google-and-meta-researchers-signs-multi-million-euro-deal-with-afp-to-counter-big-techs-content-moderation-pullback" target="_blank" rel="noreferrer noopener">has investment from </a><strong><a href="https://www.benzinga.com/25/01/43020678/french-ai-startup-founded-by-former-google-and-meta-researchers-signs-multi-million-euro-deal-with-afp-to-counter-big-techs-content-moderation-pullback" target="_blank" rel="noreferrer noopener">Microsoft.</a></strong> In 2024, Mistral raised $645 million in funding, reaching a valuation of $6 billion.</p>
<p><strong>Price Action</strong>: CSCO shares are trading higher by 0.83% at $62.79 at the last check Monday.</p>
<p><strong>Read Next</strong>:</p>
<ul>
<li><strong><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43568526/intuits-ai-market-expansion-position-it-for-long-term-growth-goldman-sachs" target="_blank" rel="noreferrer noopener">Intuit&#8217;s AI, Market Expansion Position It For Long-Term Growth</a></strong></li>
</ul>
<p><em>Photo via Shutterstock.</em></p>


Equities

Large Cap

Movers

Tech

General

CSCO

Cisco Unveils First Jointly Developed AI Agent From Mistral AI Partnership - What's On The Cards?

<p><a href="https://www.bloomberg.com/news/articles/2025-02-10/microsoft-hit-by-french-antitrust-probe-over-rivals-bing-access?srnd=phx-technology#:~:text=Microsoft%20Corp.%20is%20under%20investigation,their%20own%20search%2Dengine%20products" title="https://www.bloomberg.com/news/articles/2025-02-10/microsoft-hit-by-french-antitrust-probe-over-rivals-bing-access?srnd=phx-technology#:~:text=Microsoft%20Corp.%20is%20under%20investigation,their%20own%20search%2Dengine%20products">https://www.bloomberg.com/news/articles/2025-02-10/microsoft-hit-by-french-antitrust-probe-over-rivals-bing-access?srnd=phx-technology#:~:text=Microsoft%20Corp.%20is%20under%20investigation,their%20own%20search%2Dengine%20products</a>.</p>


Comments

Hennessy Advisors, Inc. - 4.875% Notes due 2026

Hennessy Advisors, Inc. - 4.875% Notes due 2026 (HNNAZ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga